Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/605194
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2024-12-06T08:19:14Z-
dc.date.available2024-12-06T08:19:14Z-
dc.identifier.urihttp://hdl.handle.net/10603/605194-
dc.description.abstractA metabolic disease and worldwide health issue, Type 2 diabetes mellitus (T2DM) is characterized by abnormal glucose regulation resulting from impaired insulin secretion or action. Anemia is the most prevalent disorder in T2DM patients and it is an important factor for the progression of microvascular complications. The Pathophysiological mechanism of anemia in diabetes is the decrease in erythropoietin secretion, renal impairment, alteration in iron metabolism, degradation of ferroprotein that blocks the iron transport in the duodenum, and the release of inflammatory cytokines and free radicals in the disease. Despite newly evolving treatment strategies, in most of the diabetic patients anemia remains unrecognized and untreated. Anemia is 2 to 3 times higher in diabetic patients compared to the general population. 80% of people would receive their primary medical care from medicinal plants. Extensive literature studies tell about the usage of the medicinal plant Eclipta alba as a dietary supplement or treating diseases. It has been used to treat blood problems and liver ailments as a single medication or in combination with other herbs in traditional medicine. However, there is a lack of scientific evidence regarding its usage. Thus, the purpose of this study is to demonstrate in albino rats the antihyperglycemic and antianemic properties of the medicinal herb Eclipta alba. Effects of ethanolic extract of the plant were studied in albino rats in which diabetes is induced with streptozotocin and anemia induced by phenylhydrazine. An acute toxicity investigation and a preliminary phytochemical analysis were conducted. Rats were separated into five groups, each containing six rats. Group 1 received standard saline treatment. Group ll, Diabetes induced, group lll, lV, V, treated with the standard drug, E.E.Ec.alba at the dose of 250mg /kg body weight and 500mg/kg b.w respectively for 28 days. To study the hematinic effect animals are grouped 5 and 6 in each and anemia is induced and the animals are treated with the
dc.format.extent
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleHypoglycemic and Hematinic Effect of Eclipta Alba in Experimentally Induced Type 2 Diabetes in Albino Rats
dc.title.alternative
dc.creator.researcherPrasanna, K, R
dc.subject.keywordLife Sciences
dc.subject.keywordPhysiology living organisms
dc.subject.keywordPlant and Animal Science
dc.description.note
dc.contributor.guideVijayakumar, R
dc.publisher.placeChennai
dc.publisher.universityBharath Institute of Higher Education and Research
dc.publisher.institutionFaculty of Medical Sciences
dc.date.registered
dc.date.completed2024
dc.date.awarded2024
dc.format.dimensions
dc.format.accompanyingmaterialDVD
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Faculty of Medical Sciences

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File29.46 kBAdobe PDFView/Open
02_prelim.pdf238.7 kBAdobe PDFView/Open
03_content.pdf78.5 kBAdobe PDFView/Open
04_abstract.pdf72.17 kBAdobe PDFView/Open
05_chapter 1.pdf213.93 kBAdobe PDFView/Open
06_chapter 2.pdf231.54 kBAdobe PDFView/Open
07_chapter 3.pdf209.22 kBAdobe PDFView/Open
08_chapter 4.pdf326.64 kBAdobe PDFView/Open
09_chapter 5.pdf1.1 MBAdobe PDFView/Open
10_chapter 6.pdf95.47 kBAdobe PDFView/Open
11_annexure.pdf217.8 kBAdobe PDFView/Open
11_chapter 7.pdf71.47 kBAdobe PDFView/Open
80_recommendation.pdf100.47 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: